Krish Gene Agro Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2022)
- Profit -85.48%
(FY 2022)
- Ebitda -441.67%
(FY 2022)
- Net Worth -39.68%
(FY 2022)
- Total Assets %
(FY 2022)
About Krish Gene Agro
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Agarwal, Chetan Balar, Akashbhai Chaudhari, and One other member serve as directors at the Company.
- CIN/LLPIN
U01403MH2012PTC229426
- Company No.
229426
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Krish Gene Agro?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Agarwal  | Additional Director | 31-Dec-2023 | Current |
| Chetan Balar | Director | 10-Apr-2012 | Current |
| Akashbhai Chaudhari | Additional Director | 31-Dec-2023 | Current |
| Mohibkhan Pathan | Additional Director | 31-Dec-2023 | Current |
Financial Performance of Krish Gene Agro.
Krish Gene Agro Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 85.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krish Gene Agro?
Unlock access to Krish Gene Agro's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Devbhoomi Herbs Private LimitedInactive For E-Filing 3 months 26 days
Manish Agarwal is a mutual person
- Kalyanji Bharatji Hotels And Resorts Private LimitedActive 2 years 8 months
Manish Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Krish Gene Agro?
Unlock and access historical data on people associated with Krish Gene Agro, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krish Gene Agro, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krish Gene Agro's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
